2025 Journal Article The complexities of elexacaftor/tezacaftor/ivacaftor therapeutic drug monitoring in a person with cystic fibrosis and <i>Mycobacterium abscessus</i> pulmonary diseaseMou, Claire Y, Henderson, Daniel J, Matson, Angela G, Herd, Karen M, Reid, David W, Riddles, Timothy, Johnson, Ellie, McWhinney, Brett, Swenson, Rebecca, Burke, Andrew and Evans, Ieuan E S (2025). The complexities of elexacaftor/tezacaftor/ivacaftor therapeutic drug monitoring in a person with cystic fibrosis and Mycobacterium abscessus pulmonary disease. European Clinical Respiratory Journal, 12 (1) 2458341, 2458341. doi: 10.1080/20018525.2025.2458341 |
2025 Journal Article Evaluating the feasibility, sensitivity, and specificity of next-generation molecular methods for pleural infection diagnosisBell, Peter T., Baird, Timothy, Goddard, John, Olagoke, Olusola S., Burke, Andrew, Subedi, Shradha, Davey, Tiana R., Anderson, James, Sarovich, Derek S. and Price, Erin P. (2025). Evaluating the feasibility, sensitivity, and specificity of next-generation molecular methods for pleural infection diagnosis. Microbiology Spectrum, 13 (2). doi: 10.1128/spectrum.01960-24 |
2024 Conference Publication Rifabutin induces Elexacaftor metabolism in Mycobacterium abscessus-related pulmonary disease: A case studyMattison, Graeme, Keating, Rebecca, McWhinney, Brett, Connors, Shannon, Swenson, Rebecca, Evans, Ieuan, Burke, Andrew and Burr, Lucy (2024). Rifabutin induces Elexacaftor metabolism in Mycobacterium abscessus-related pulmonary disease: A case study. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD Australia, 2–4 August 2024. Richmond, VIC Australia: John Wiley & Sons. |
2024 Journal Article New oxazolidinones for tuberculosis: are novel treatments on the horizon?Chen, Ricky Hao, Burke, Andrew, Cho, Jin-Gun, Alffenaar, Jan-Willem and Davies Forsman, Lina (2024). New oxazolidinones for tuberculosis: are novel treatments on the horizon?. Pharmaceutics, 16 (6) 818. doi: 10.3390/pharmaceutics16060818 |
2024 Journal Article OPTIMA: an open-label, non-comparative pilot trial of inhaled molgramostim in pulmonary nontuberculous mycobacterial infectionThomson, Rachel M., Loebinger, Michael R., Burke, Andrew J., Morgan, Lucy C., Waterer, Grant W. and Ganslandt, Cecilia (2024). OPTIMA: an open-label, non-comparative pilot trial of inhaled molgramostim in pulmonary nontuberculous mycobacterial infection. Annals of the American Thoracic Society, 21 (4), 568-576. doi: 10.1513/annalsats.202306-532oc |
2024 Journal Article Prevalence, risk factors, clinical features, and outcome of Influenza-Associated Pulmonary Aspergillosis (IAPA) in critically ill patients: a systematic review and meta-analysisLu, Lawrence Y., Lee, Hui Min, Burke, Andrew, Li Bassi, Gianluigi, Torres, Antoni, Fraser, John F. and Fanning, Jonathon P. (2024). Prevalence, risk factors, clinical features, and outcome of Influenza-Associated Pulmonary Aspergillosis (IAPA) in critically ill patients: a systematic review and meta-analysis. CHEST, 165 (3), 540-558. doi: 10.1016/j.chest.2023.09.019 |
2024 Journal Article A case of severe Mycobacterium thermoresistibile pneumoniaSubramaniam, Selvaraj, Kanhere, Mrudula, Shephard, Lisa, Burke, Andrew, Saxon, Sarah and Geake, James (2024). A case of severe Mycobacterium thermoresistibile pneumonia. Respirology Case Reports, 12 (3) e01308, 1-6. doi: 10.1002/rcr2.1308 |
2023 Journal Article Medications and monitoring in treatment of nontuberculous mycobacteria lung diseaseSawka, Alice and Burke, Andrew (2023). Medications and monitoring in treatment of nontuberculous mycobacteria lung disease. Clinics in Chest Medicine, 44 (4), 815-828. doi: 10.1016/j.ccm.2023.06.012 |
2023 Journal Article A randomized trial of Nafamostat for Covid-19Morpeth, Susan C., Venkatesh, Balasubramanian, Totterdell, James A., McPhee, Grace M., Mahar, Robert K., Jones, Mark, Bandara, Methma, Barina, Lauren A., Basnet, Bhupendra K., Bowen, Asha C., Burke, Andrew J., Cochrane, Belinda, Denholm, Justin T., Dhungana, Ashesh, Dore, Gregory J., Dotel, Ravindra, Duffy, Eamon, Dummer, Jack, Foo, Hong, Gilbey, Timothy L., Hammond, Naomi E., Hudson, Bernard J., Jha, Vivekanand, Jevaji, Purnima R., John, Oommen, Joshi, Rajesh, Kang, Gagandeep, Kaur, Baldeep, Kim, Seungtaek ... Tong, Steven Y.C. (2023). A randomized trial of Nafamostat for Covid-19. NEJM Evidence, 2 (11). doi: 10.1056/evidoa2300132 |
2023 Journal Article In vitro susceptibility testing of imipenem- relebactam and tedizolid against 102 Mycobacterium abscessus isolatesBurke, Andrew, Carter, Robyn, Tolson, Carla, Congdon, Jacob, Duplancic, Christine, Bursle, Evan, Bell, Scott C., Roberts, Jason A. and Thomson, Rachel (2023). In vitro susceptibility testing of imipenem- relebactam and tedizolid against 102 Mycobacterium abscessus isolates. International Journal of Antimicrobial Agents, 62 (4) 106938, 1-6. doi: 10.1016/j.ijantimicag.2023.106938 |
2023 Journal Article Pre-XDR congenital tuberculosis in an extremely premature babyBoast, Alison, How, Jeu Ann, Lau, Charis, Sett, Arun, Gilby, Damian, Burke, Andrew, McWhinney, Brett, Wright, Connor, Tramontana, Adrian, Globan, Maria, Denholm, Justin, Graham, Stephen M and Osowicki, Joshua (2023). Pre-XDR congenital tuberculosis in an extremely premature baby. Clinical Infectious Diseases, 78 (1), 149-153. doi: 10.1093/cid/ciad540 |
2023 Journal Article A mariner's tale: invasive endotracheal Mycobacterium marinum infectionBell, Peter T., Anderson, James, Coulter, Christopher, Dettrick, Andrew J., Burke, Andrew and Baird, Timothy (2023). A mariner's tale: invasive endotracheal Mycobacterium marinum infection. Respirology Case Reports, 11 (10) e01211, e01211. doi: 10.1002/rcr2.1211 |
2023 Journal Article Mycoplasma hominis and Ureaplasma urealyticum infections in the immediate post-lung transplant period: A case series and literature reviewDivithotewala, Chandima, Sweeney, Emma L., Burke, Andrew, Graves, Bianca, Stewart, Adam, Whiley, David, Heney, Claire, Hopkins, Peter M. and Chambers, Daniel C. (2023). Mycoplasma hominis and Ureaplasma urealyticum infections in the immediate post-lung transplant period: A case series and literature review. Transplant Infectious Disease, 25 (3) e14058, 1-7. doi: 10.1111/tid.14058 |
2023 Journal Article Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator ModulatorsBurke, Andrew, Thomson, Rachel M., Wainwright, Claire E. and Bell, Scott C. (2023). Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator Modulators. Seminars in Respiratory and Critical Care Medicine, 44 (02), 287-296. doi: 10.1055/s-0042-1759883 |
2022 Journal Article Anticoagulation strategies in non–critically ill patients with Covid-19McQuilten, Zoe K., Venkatesh, Balasubramanian, Jha, Vivekanand, Roberts, Jason, Morpeth, Susan C., Totterdell, James A., McPhee, Grace M., Abraham, John, Bam, Niraj, Bandara, Methma, Bangi, Ashpak K., Barina, Lauren A., Basnet, Bhupendra K., Bhally, Hasan, Bhusal, Khema R., Bogati, Umesh, Bowen, Asha C., Burke, Andrew J., Christopher, Devasahayam J., Chunilal, Sanjeev D., Cochrane, Belinda, Curnow, Jennifer L., Das, Santa Kumar, Dhungana, Ashesh, Di Tanna, Gian Luca, Dotel, Ravindra, DSouza, Hyjel, Dummer, Jack, Dutta, Sourabh ... Tong, Steven Y.C. (2022). Anticoagulation strategies in non–critically ill patients with Covid-19. NEJM Evidence, 2 (2). doi: 10.1056/evidoa2200293 |
2022 Journal Article Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (±talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusionFitzgerald, Deirdre B., Sidhu, Calvin, Budgeon, Charley, Tan, Ai Ling, Read, Catherine A., Kwan, Benjamin C. H., Smith, Nicola Ann, Fysh, Edward T., Muruganandan, Sanjeevan, Saghaie, Tajalli, Shrestha, Ranjan, Badiei, Arash, Nguyen, Phan, Burke, Andrew, Goddard, John, Windsor, Morgan, McDonald, Julie, Wright, Gavin, Czarnecka, Kasia, Sivakumar, Parthipan, Yasufuku, Kazuhiro, Feller-Kopman, David J., Maskell, Nick A., Murray, Kevin and Lee, Y. C. Gary (2022). Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (±talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion. Trials, 23 (1) 530, 1-9. doi: 10.1186/s13063-022-06405-7 |
2022 Conference Publication Anticoagulation and antiplatelet strategies in non-critically ill patients with Covid-19McQuilten, Zoe, Venkatesh, Balasubramanian, Jha, Vivekanand, Roberts, Jason, Morpeth, Susan, Totterdell, James, McPhee, Grace, Abraham, John, Bam, Niraj, Bandara, Methma, Bangi, Ashpak, Barina, Lauren, Basnet, Bhupendra, Bhally, Hasan, Bhusal, Khemr, Bogati, Umesh, Bowen, Asha, Burke, Andrew, Christopher, Devasahayam, Chunilal, Sanjeev, Cochrane, Belinda, Curnow, Jennifer, Reddy, Varaprasad Babu Dara, Das, Santa, Dhungana, Ashesh, Di Tanna, Gian Luca, Dotel, Ravindra, DSouza, Hyjel, Dummer, Jack ... Tong, Steven Y. C. (2022). Anticoagulation and antiplatelet strategies in non-critically ill patients with Covid-19. 64th Annual Meeting and Exposition of the American Society of Hematology (ASH), New Orleans, LA United States, 10-13 December 2022. Amsterdam, Netherlands: Elsevier. doi: 10.1182/blood-2022-168448 |
2022 Journal Article The IRIS paradox: Imaging findings in a case of PJP-IRISReddy, Taryn, Bajwa, Ramey and Burke, Andrew (2022). The IRIS paradox: Imaging findings in a case of PJP-IRIS. Respirology Case Reports, 10 (9) e01014. doi: 10.1002/rcr2.1014 |
2022 Journal Article Screening for obstructive sleep apnoea in patients with serious mental illnessZhang, Lai-Ying, Anderson, James, Higgins, Niall, Robinson, Jan, Francey, Sonia, Burke, Andrew, Robinson, Gail, Curtin, Deanne and Tay, George (2022). Screening for obstructive sleep apnoea in patients with serious mental illness. Australasian Psychiatry, 30 (5), 615-618. doi: 10.1177/10398562221108632 |
2022 Journal Article Evidence of safety for pretomanid and male reproductive healthBurke, A., Alffenaar, J. and Denholm, J. (2022). Evidence of safety for pretomanid and male reproductive health. The International Journal of Tuberculosis and Lung Disease, 26 (6), 473-474. doi: 10.5588/ijtld.22.0092 |